DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Effective December 12, 2017, DENTSPLY SIRONA Inc. (the “Company”) appointed Nicholas W. Alexos, Executive Vice President and Chief Financial Officer, as principal accounting officer for purposes of the Company’s filings with the Securities and Exchange Commission in addition to his current role. Mr. Alexos, age 54, will oversee the Company’s accounting matters.

Since November 10, 2017, Mr. Alexos has served as the Executive Vice President and Chief Financial Officer of the Company. Prior to assuming the role of Executive Vice President and Chief Financial Officer for the Company, from January 1993 to October 2017, Mr. Alexos served as Managing Director of Madison Dearborn Partners LLC, a Chicago-based private equity firm which he co-founded, where he was responsible for investment activities in healthcare and general management of the firm. Mr. Alexos is a certified public accountant and he received his B.B.A. from Loyola University and an M.B.A. from The University of Chicago Booth School of Business.

Mr. Alexos has no family relationships with any director, executive officer, or person nominated or chosen by the Company to become an officer of the Company. Mr. Alexos is not a party to any transaction required to be disclosed to Item 404(a) of Regulation S-K.

About DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s segments include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company distributes its products in over 120 countries. It offers brands, such as ANKYLOS, AQUASIL ULTRA, ARTICADENT, XIVE, ORAQIX, XYLOCAINE, ZHERMACK, IN-OVATION, LOFRIC, MAILLEFER, MIDWEST, NUPRO, ORIGO, OSSEOSPEED and PALODENT PLUS.